Clinical Trial: NCT01525966
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer
Status:
ACTIVE NOT RECRUITINGPhase:
Phase 2| Lead Sponsor: | City of Hope Medical Center |
| Information Provided By: | City of Hope Medical Center |
| Last Update Posted: | 2026-10-29 |
Study Overview
Brief Summary
This phase II trial studies how well carboplatin and nab-paclitaxel before surgery work in treating patients with triple negative breast cancer that is inflammatory or has spread from where it started to nearby tissue or lymph nodes. Drugs used in chemotherapy, such as carboplatin and nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed.
Official Title
Conditions
Intervention / Treatment
- Drug: carboplatin
- Drug: paclitaxel albumin-stabilized nanoparticle formulation
- Other: laboratory biomarker analysis
Other Study ID Numbers
- 11174
- NCI-2012-00025
Start Date (Actual)
Primary Completion Date (Actual)
Study Completion Date (Estimated)
Enrollment (Actual)
Study Type
Phase
| Lead Sponsor: | City of Hope Medical Center |
| Information Provided By: | City of Hope Medical Center |
| Last Update Posted: | 2026-10-29 |
Study Overview
Brief Summary
This phase II trial studies how well carboplatin and nab-paclitaxel before surgery work in treating patients with triple negative breast cancer that is inflammatory or has spread from where it started to nearby tissue or lymph nodes. Drugs used in chemotherapy, such as carboplatin and nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed.
Official Title
Conditions
Intervention / Treatment
- Drug: carboplatin
- Drug: paclitaxel albumin-stabilized nanoparticle formulation
- Other: laboratory biomarker analysis
Other Study ID Numbers
- 11174
- NCI-2012-00025